Therefore, the use of HSP90α inhibitors alone or in combination with chemoradiotherapy or immunotherapy may be one of the treatment methods to improve the prognosis of metastatic colorectal cancer. The gene discussed is HSP90AA1; the disease is metastatic colorectal cancer.